HER2 testing in gastric cancer: An update

被引：201
|
作者：
Abrahao-Machado, Lucas Faria [1 ]
Scapulatempo-Neto, Cristovam [1 ]
机构：
[1] Barretos Canc Hosp, Dept Pathol, Rua Antenor Duarte Villela 1331, BR-14784400 Barretos, SP, Brazil
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2016年 / 22卷 / 19期
关键词：
Human epidermal growth factor receptor 2 testing; Gastric cancer; Immunohistochemistry; Scoring system; Trastuzumab; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; HELICOBACTER-PYLORI; SCORING SYSTEM; EXPRESSION; FISH; VALIDATION; PROGNOSIS; CARCINOMA; OVEREXPRESSION;
D O I：
10.3748/wjg.v22.i19.4619
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Human epidermal growth factor receptor 2 (HER2) overexpression is increasingly recognized as a frequent molecular abnormality in gastric and gastroesophageal cancer. With the recent introduction of HER2 molecular targeted therapy for patients with advanced gastric cancer, determination of HER2 status is crucial in order to select patients who may benefit from this treatment. This paper provides an update on our knowledge of HER2 in gastric and gastroesophageal cancer, including the prognostic relevance of HER2, the key differences between HER2 protein expression interpretation in breast and gastric cancer, the detection methods and the immunohistochemistry scoring system.
引用
收藏
页码：4619 / 4625
页数：7
相关论文
共 50 条
  • [41] Update on HER2 testing for breast and upper gastrointestinal tract cancers
    Ross, Jeffrey S.
    BIOMARKERS IN MEDICINE, 2011, 5 (03) : 307 - 318
  • [42] IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status
    Damasceno, Emanuel Adelino M.
    Carneiro, Fabiana Pirani
    de Magalhaes, Albino Vercosa
    Carneiro, Marcos de Vasconcelos
    Soares Takano, Gustavo Henrique
    de Sousa Vianna, Leonora Maciel
    Kohnert Seidler, Heinrich Bender
    Mendes Lousa de Castro, Tercia Maria
    Muniz-Junqueira, Maria Imaculada
    Batista Amorim, Rivadavio Fernandes
    Moraes Ferreira, Vania Maria
    Motoyama, Andrea Barreto
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (12) : 2163 - 2168
  • [43] 'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer
    Santini, D.
    Vincenzi, B.
    Pantano, F.
    Schiavon, G.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1715 - 1717
  • [44] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [45] HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
    Eric Van Cutsem
    Yung-Jue Bang
    Feng Feng-yi
    Jian M. Xu
    Keun-Wook Lee
    Shun-Chang Jiao
    Jorge León Chong
    Roberto I. López-Sanchez
    Timothy Price
    Oleg Gladkov
    Oliver Stoss
    Julie Hill
    Vivian Ng
    Michaela Lehle
    Marlene Thomas
    Astrid Kiermaier
    Josef Rüschoff
    Gastric Cancer, 2015, 18 : 476 - 484
  • [46] Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients
    Sasaki, Takahide
    Fuse, Nozomu
    Kuwata, Takeshi
    Nomura, Shogo
    Kaneko, Kazuhiro
    Doi, Toshihiko
    Yoshino, Takayuki
    Asano, Hiromichi
    Ochiai, Atsushi
    Komatsu, Yoshito
    Sakamoto, Naoya
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 43 - 48
  • [47] Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China
    Xu, Chen
    Sun, Miaomiao
    Jin, Mei
    Li, Zengshan
    Qin, Rong
    Ren, Guoping
    Sun, Wenyong
    Chen, Lirong
    Luan, Lijuan
    Liu, Yalan
    Jiang, Dongxian
    Chen, Lingli
    Luo, Rongkui
    Hou, Yingyong
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [48] HER2 in Breast Cancer: A Review and Update
    Krishnamurti, Uma
    Silverman, Jan F.
    ADVANCES IN ANATOMIC PATHOLOGY, 2014, 21 (02) : 100 - 107
  • [49] HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing
    Rueschoff, Josef
    Dietel, Manfred
    Baretton, Gustavo
    Arbogast, Susanne
    Walch, Axel
    Monges, Genevieve
    Chenard, Marie-Pierre
    Penault-Llorca, Frederique
    Nagelmeier, Iris
    Schlake, Werner
    Hoefler, H.
    Kreipe, H. H.
    VIRCHOWS ARCHIV, 2010, 457 (03) : 299 - 307
  • [50] UK recommendations for HER2 assessment in breast cancer: an update
    Rakha, Emad A.
    Tan, Puay Hoon
    Quinn, Cecily
    Provenzano, Elena
    Shaaban, Abeer M.
    Deb, Rahul
    Callagy, Grace
    Starczynski, Jane
    Lee, Andrew H. S.
    Ellis, Ian O.
    Pinder, Sarah E.
    JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (04) : 217 - 227
12345